Avalo Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | – | – | – | 100.0% | – | – | 100.0% | |
| 304.7% | 1,267.2% | 230.8% | 134.3% | 150.2% | 2.2% | 19.3% | 29.7% | 76.4% | 41.7% | 36.0% | 72.3% | 25.6% | – | 2.4% | 5.8% | 6.9% | 708.8% | 16.3% | 296.8% | 67.3% | 4,000.0% | 61.4% | 151.7% | 3.5% | 69.2% | 1,049.1% | 110.1% | 101.7% | -38.7% | – | – | -286.7% | 45.3% | – | – | – | 27.1% | – | – | – | |
| -204.7% | -1,167.2% | -130.8% | -34.3% | -50.2% | 97.8% | 80.7% | 70.3% | 23.6% | 58.3% | 64.0% | 27.7% | 74.4% | – | 97.6% | 94.2% | 93.1% | -608.8% | 83.7% | -196.8% | 32.7% | -3,900.0% | 38.6% | -51.7% | 96.5% | 30.8% | -949.1% | -10.1% | -1.7% | 138.7% | – | – | 386.7% | 54.7% | – | – | – | 100.0% | – | – | – | |
| 384.6% | 1,425.1% | 424.7% | 248.1% | 312.8% | 3.9% | 36.8% | 22.6% | 25.7% | 40.3% | 62.9% | 83.4% | 31.1% | – | 173.1% | 442.2% | 798.6% | 844.2% | 5,329.0% | 374.6% | 781.6% | 5,255.7% | 817.1% | 823.8% | 47.1% | 688.8% | 1,264.8% | 724.4% | 529.2% | 327.0% | – | – | 3,830.5% | 4,262.0% | – | – | – | 22,486.4% | – | – | 109,072.9% | |
| 251.6% | 529.8% | 601.6% | 346.2% | 912.0% | 8.6% | 65.1% | 63.6% | 46.2% | 57.0% | 50.2% | 53.5% | 47.7% | – | 97.2% | 456.0% | 411.6% | 302.1% | 1,038.3% | 207.8% | 403.3% | 1,974.4% | 831.7% | 268.2% | 21.9% | 328.9% | 567.4% | 376.4% | 1,055.1% | 467.4% | – | – | 1,664.3% | 2,314.6% | – | – | – | 10,428.8% | – | – | 44,945.8% | |
| 636.2% | 1,954.9% | 1,026.4% | 594.3% | 1,224.8% | 12.4% | 158.6% | 154.6% | 154.8% | 174.5% | 190.4% | 227.2% | 144.1% | – | 1,238.2% | 977.2% | 1,288.1% | 4,257.1% | 6,548.8% | 595.3% | 1,252.2% | 4,302.3% | 1,816.4% | 1,093.3% | 69.1% | 1,019.1% | 901.9% | 1,101.9% | 1,587.3% | 795.6% | – | – | 5,551.8% | 6,987.5% | – | – | – | 33,561.0% | – | – | 137,983.1% | |
| -536.2% | -1,854.9% | -926.4% | -494.3% | -1,124.8% | 87.6% | -77.9% | -119.9% | -594.6% | -117.5% | -129.8% | -134.3% | -66.2% | – | -1,140.6% | -883.0% | -1,195.0% | -4,865.9% | -6,465.1% | -792.1% | -1,219.5% | -8,202.3% | -1,777.7% | -1,145.0% | 27.4% | -988.3% | -1,850.9% | -1,112.0% | -1,589.0% | -656.9% | – | – | -5,165.1% | -6,932.8% | – | – | – | -33,461.0% | – | – | -154,844.1% | |
| 19.5% | 32.4% | 45.6% | 15.0% | 16.2% | 0.1% | 2.2% | 5.1% | 5.8% | 4.7% | 3.8% | 4.5% | 3.7% | – | 0.4% | 0.7% | – | 1.2% | 3.6% | 7.1% | 73.0% | 540.6% | 99.7% | 111.7% | 6.0% | 105.9% | 199.8% | 154.9% | 658.1% | 14.2% | – | – | 387.1% | – | – | – | – | – | – | – | – | |
| -541.8% | -1,918.8% | -900.5% | -510.3% | -1,139.7% | 87.7% | -86.1% | -125.2% | -602.5% | -114.1% | -134.7% | -138.4% | -69.5% | – | -882.8% | -992.5% | -1,193.3% | -1,090.7% | -6,461.5% | -506.0% | -1,293.6% | -8,728.3% | -1,879.1% | -1,256.7% | 21.4% | -1,094.2% | -2,094.1% | -1,273.1% | -2,211.9% | -1,432.0% | – | – | 9,246.2% | -18,346.4% | – | – | – | -23,033.9% | – | – | -169,766.1% | |
| 5.6% | 63.9% | -29.3% | 16.0% | 14.9% | 12.9% | 0.5% | 0.3% | 1.3% | -2.5% | 3.1% | 1.5% | 2.1% | – | -78.3% | -33.9% | 0.3% | -12.4% | 2.3% | 5.9% | 0.6% | 7.3% | 0.8% | 0.5% | 0.0% | 0.9% | 1.7% | 1.1% | 3.4% | -1.6% | – | – | -5.6% | 59.4% | – | – | – | 220.3% | – | – | 289.8% | |
| -541.8% | -1,918.8% | -900.5% | -510.3% | -1,139.7% | 74.8% | -86.6% | -125.5% | -603.8% | -111.5% | -137.7% | -139.9% | -71.6% | – | -766.8% | -992.6% | -1,211.4% | -1,045.0% | -6,486.3% | -509.8% | -1,288.5% | -8,765.3% | -1,879.9% | -1,257.2% | 21.4% | -1,095.1% | -2,095.8% | -1,274.2% | -2,215.3% | -1,430.5% | – | – | 9,251.8% | -18,405.7% | – | – | – | -23,254.2% | – | – | -170,055.9% | |
| -535.2% | -1,852.7% | -923.1% | -492.8% | -1,121.1% | 87.6% | -61.0% | -50.1% | -104.9% | -84.9% | -71.8% | -109.0% | -46.9% | – | -196.5% | -851.2% | -1,155.0% | -1,109.0% | -6,369.8% | -497.0% | -1,186.9% | -8,053.0% | -1,773.7% | -1,142.1% | 27.6% | -984.4% | -1,887.4% | -1,111.8% | -1,536.4% | -1,438.7% | – | – | 9,259.8% | -18,310.9% | – | – | – | -23,006.8% | – | – | -169,581.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.